Blood markers and liver scarring in type 2 diabetes
Part of Digestive system clinical trials.
This study looks at whether two blood markers (adiponectin and resistin) can help show how much liver scarring (fibrosis) is present in people with type 2 diabetes and fatty liver disease. It may help doctors find better ways to check liver health without a biopsy.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must have been diagnosed with type 2 diabetes for less than 5 years.
- You should not drink alcohol heavily or have a history of alcohol abuse.
- You should not have other chronic liver diseases or abnormal liver tests.
- You should not have a severe infection currently.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study is for people with type 2 diabetes who may have early liver damage (fatty liver) but haven't yet developed severe scarring. It tests a simple screening program to find advanced liver fibrosis early, so it can be treated sooner.
This study looks at how well a simple blood test (called FIB-4) can measure liver damage (fibrosis) in people with type 2 diabetes. You may join to help find out if this test can help detect liver problems early.
This study looks at whether simple blood tests can help predict liver scarring (fibrosis) in people with fatty liver disease. If you join, you'll have a quick, non-invasive scan of your liver to check for fat and scarring.
This study aims to find a simple way to detect liver fibrosis, a condition where the liver becomes scarred, in people who have risk factors like being overweight, having type 2 diabetes, or drinking alcohol heavily. By identifying fibrosis early, it may help prevent more serious liver problems.
This study looks at how certain blood tests (liver biomarkers) change in people with higher risk for liver disease. It may help doctors understand who is developing liver problems earlier and what patterns in blood tests matter most.
This study is looking for people with type 2 diabetes and fatty liver disease to find better ways to track how the disease progresses. They will use special tests (biomarkers) to see if the liver is getting worse over time.
Hear when a new Hepatic Fibrosis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.